The global Influenza Vaccine Market was valued at US$ 7.54 Billion in 2022 and is projected to reach USD 13.58 Billion by 2030, growing at a CAGR of 8.8% from 2023 to 2030. Global Influenza Vaccine Market Reports give a Key study on the industry status of the Influenza Vaccine Industry Manufacturer with the specific statistics, meaning, definition, SWOT Analysis, expert opinion, and recent development across the globe. The research report also covers the Market Size, Price, Sales, Revenue, Market share, Gross Margin, growth rate, and cost structure. The report aims to give an additional sample of the latest scenario, economic slowdown, and Covid-19 impact on overall Industry.
Buy Full Report @
https://www.contrivedatuminsights.com/buy/248488
In 2022, each year, flu viruses cause epidemics and outbreaks in certain areas that kill thousands of people. the World Health Organization (WHO) reported that there were between 3.0 and 5.0 million cases of severe influenza, which killed 650,000 people around the world. To keep up with the changing nature of the influenza virus, the strain of the vaccine needs to be changed every year. During the forecast period, sales will go up because there will be more flu epidemics and seasonal outbreaks.
The World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and other government agencies currently recommend a number of licenced seasonal influenza vaccines to fight the disease. Also, governments tell people to get vaccinated as soon as possible to be as safe as possible during flu season. Also, when making a vaccine against a certain strain, pharmaceutical companies keep running into new problems. Because of this, the need for effective flu vaccines is expected to drive the global market for flu vaccines.
The Coronavirus pandemic affects both developing and developed countries’ routine immunisation programmes and campaigns. During the pandemic, though, more people got vaccinated because of things like pressure from health officials and the growth of government programmes that gave away free flu medicines. One reason for the rise in flu vaccine use is that more people are learning that if the flu weakens your immune system, you are more likely to get COVID-19.
Competitive Landscape and Global Market Share Analysis:
GlaxoSmithKline plc (U.K.), Sanofi (France), AstraZeneca (U.K.), CSL Limited (Australia), BIKEN Co., Ltd. (Japan), Abbott (U.S.), SINOVAC (China), Viatris Inc. (U.S.), Others
Market Segmentation:
By Type
- Inactivated
- Live Attenuated
By Valency
- Quadrivalent
- Trivalent
By Age Group
- Pediatric
- Adults
By Distribution Channel
- Hospital & Retail Pharmacies
- Government Suppliers
- Others
The report on the Influenza Vaccine market covers the following region (country) analysis:
- North America (U.S., Canada)
- Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
- South America (Mexico, Brazil, Argentina, Columbia, Rest of South America)
- Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)
Regional Insights:
During the period of the Forecast, North America is expected to have the biggest market by region.
In 2021, sales in North America were worth $3.76 billion, making it the biggest market in the world. The growth of the market in the region is likely to be fueled by the quick release of effective products and the spread of technologically advanced systems for making vaccines across the region. In North America, too, the market is likely to grow because more people are getting flu shots and there are more flu cases.
Asia Pacific is expected to have a higher CAGR during the time frame of the forecast. The number of government programmes to give flu shots and teach people about the flu is likely to drive the growth of the market in the region. The market is also expected to grow because countries like China and India are getting more people, and people want effective vaccines. This will lead to more sales. During the time period covered by the forecast, Latin America, the Middle East, and Africa are likely to grow a lot. This is because more people are learning about the flu virus and the government is working harder to get everyone vaccinated. The market grows because of this.
Following are the major TOC of the Influenza Vaccine Market:
Chapter 1: Influenza Vaccine Market Overview
Chapter 2: Global Economic Impact on Industry
Chapter 3: Global Influenza Vaccine Market Competition by Manufacturers
Chapter 4: Global Production, Profits (Value) by Region
Chapter 5: Global Supply (Production), Import, Export, Consumption, by Regions
Chapter 6: Global Price Trend by Type, Revenue (Value), Production
Chapter 7: Manufacturing Cost Analysis
Chapter 8: Global Market Analysis by Application
Chapter 9: Industrial Chain and Downstream Buyers, Sourcing Strategy
Chapter 10: Marketing Strategy Analysis, Distributors/Traders
Chapter 11: Market Effect Factors Analysis
Chapter 12: Global Influenza Vaccine Market Forecast
Browse Full Report and TOC:
https://www.contrivedatuminsights.com/product-report/influenza-vaccine-market-248488
Key Reasons to Purchase Influenza Vaccine Market report:
The report provides a thorough examination of the manufacturing methods, as well as ideas to reduce development risk, major market growth challenges and strategic inputs to overcome the market threats.
In-depth market analysis and an overview of the global Influenza Vaccine Market trend and commercial landscape are included in the report. In addition, the report discusses the effect of COVID-19 on the market.
Reader can acquire a better interpretation of the Influenza Vaccine Market forecast’s future view and opportunities from the report.
The report contains an analysis of recent developments as well as profiles of important market leaders and key players.
To gain an understanding of the market strategies by the leading market players in the Influenza Vaccine
The report analyses the most important driving and restraining factors in the industry, as well as their impact on global market growth.
About Us:
Contrive Datum Insights (CDI) is a global delivery partner of market intelligence and consulting services to officials in various sectors including investment, information technology, telecommunications, consumer technology, and manufacturing markets. CDI helps investment communities, business executives and IT professionals make accurate, statistically-based decisions on technology purchases and promote strong growth tactics to maintain market competitiveness. Composed of a team of more than 100 analysts and a cumulative market experience of more than 200 years, Contrive Datum Insights guarantees the delivery of industry knowledge combined with global and national experience.
Contact Us:
Anna B. (Head Of sales) | Contrive Datum Insights
Contact No- +91 9834816757 / +1 2152974078
anna@contrivedatuminsights.com